EPIGENETIC REGULATION OF F508DEL-CFTR IN CYSTIC FIBROSIS LUNG DISEASE

被引：0
|
作者：
Kumar, P. [1 ]
Frizzell, R. A. [2 ]
Pollard, H. [1 ]
Biswas, R. [1 ]
机构：
[1] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA
[2] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA
来源：
PEDIATRIC PULMONOLOGY | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
34
引用
收藏
页码：S226 / S226
页数：1
相关论文
共 50 条
  • [1] EPIGENETIC REGULATION OF F508DEL-CFTR CYSTIC FIBROSIS LUNG DISEASE: ROLE OF NEAT1 AND SFPQ IN INFLAMMATION AND CFTR FUNCTION
    Kumar, P.
    Sen, C.
    Larsen, M. B.
    Karulupalle, S.
    Frizzell, R. A.
    Pollard, H. B.
    Biswas, R.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S186 - S186
  • [2] Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR
    Taylor-Cousar, Jennifer L.
    Jain, Manu
    Barto, Tara Lynn
    Haddad, Tarik
    Atkinson, Jeffrey
    Tian, Simon
    Tang, Rui
    Marigowda, Gautham
    Waltz, David
    Pilewski, Joseph
    JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (02) : 228 - 235
  • [3] Targeting the root cause of cystic fibrosis: rescuing F508del-CFTR
    Smith, Tanya A.
    Liu, Jia
    Kaura, Amit
    Sheppard, David N.
    SCOTTISH MEDICAL JOURNAL, 2014, 59 (01) : E31 - E31
  • [4] Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis
    Speranza Esposito
    Antonella Tosco
    Valeria R. Villella
    Valeria Raia
    Guido Kroemer
    Luigi Maiuri
    Molecular and Cellular Pediatrics, 3 (1)
  • [5] Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
    De Stefano, Daniela
    Villella, Valeria R.
    Esposito, Speranza
    Tosco, Antonella
    Sepe, Angela
    De Gregorio, Fabiola
    Salvadori, Laura
    Grassia, Rosa
    Leone, Carlo A.
    De Rosa, Giuseppe
    Maiuri, Maria C.
    Pettoello-Mantovani, Massimo
    Guido, Stefano
    Bossi, Anna
    Zolin, Anna
    Venerando, Andrea
    Pinna, Lorenzo A.
    Mehta, Anil
    Bona, Gianni
    Kroemer, Guido
    Maiuri, Luigi
    Raia, Valeria
    AUTOPHAGY, 2014, 10 (11) : 2053 - 2074
  • [6] Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR
    Donaldson, Scott H.
    Pilewski, Joseph M.
    Griese, Matthias
    Cooke, Jon
    Viswanathan, Lakshmi
    Tullis, Elizabeth
    Davies, Jane C.
    Lekstrom-Himes, Julie A.
    Wang, Linda T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (02) : 214 - 224
  • [7] Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR
    Rowe, Steven M.
    McColley, Susanna A.
    Rietschel, Ernst
    Li, Xiaolei
    Bell, Scott C.
    Konstan, Michael W.
    Marigowda, Gautham
    Waltz, David
    Boyle, Michael P.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (02) : 213 - 219
  • [8] Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
    Flume, Patrick A.
    Liou, Theodore G.
    Borowitz, Drucy S.
    Li, Haihong
    Yen, Karl
    Ordonez, Claudia L.
    Geller, David E.
    CHEST, 2012, 142 (03) : 718 - 724
  • [9] Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis
    Zhi-wei Cai
    Jia Liu
    Hong-yu Li
    David N Sheppard
    Acta Pharmacologica Sinica, 2011, 32 : 693 - 701
  • [10] Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis
    Cai, Zhi-wei
    Liu, Jia
    Li, Hong-yu
    Sheppard, David N.
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (06) : 693 - 701
12345